We consider: Your complete health history Underlying causes of weight gain or blood sugar problems Your goals, preferences, and lifestyle Affordable alternatives or supportive options (nutrition plans, supplements, fitness strategies) Whether or not GLP-1 medications are part of your treatment plan, well help you find a safe, sustainable path forward
Such medications are not designed to create overnight changes
What to track during Phase 1: Nausea frequency and severity (scale of 1 to 10) Appetite changes (especially 24 to 48 hours post-injection) Any GI symptoms (constipation, diarrhea, bloating) Injection site reactions Baseline weight and measurements Do not expect dramatic results here
Currently a research peptide, it is hoped in the future it could offer a therapeutic treatment for the following: Hypoactive Sexual Desire Disorder PT-141 peptide stimulates sexual desire and arousal in individuals with hypoactive sexual desire disorder (HSDD) through its unique mechanism of action
Remember, GLP-1 triggers insulin secretion and blocks the release of glucagon